Andere talen Acarix AB Deutsche Boerse AG

Aandelen

Beurs gesloten - Deutsche Boerse AG Andere beurzen 09:11:14 31-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,029 ^EUR	+9,02%		+14,17%	+90,79%

27/05	Acarix AB (Publ) benoemt Jeff Thomas tot het nieuwe hoofd van de verkoop in de VS, met ingang van 1 juni 2024	CI
14/05	Transcript : Acarix AB, Q1 2024 Earnings Call, May 14, 2024

Acarix AB Appoints Jeff Thomas as the New Head of US Sales, Effective June 1, 2024	27/05
Transcript : Acarix AB, Q1 2024 Earnings Call, May 14, 2024	14/05
Acarix AB Approves Board Elections	14/05
Acarix AB Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Acarix Secures Multi-Unit Order from Major Cardiology Practice with Several Offices in Florida	13/05
Acarix Receives Order from the First Freestanding Emergency Room in the Us	29/04
Acarix AB Announces Initiation of the First Us-Based Clinical Workflow Evaluation Study	11/04
Acarix Announces the Results from 2024 American College of Cardiology Poster Presentation to Assess the Cost-Utility of the Cadscor System	08/04
Transcript : Acarix AB, Q4 2023 Earnings Call, Feb 15, 2024	15/02
Acarix Appoints New Members to the Advisory Board	15/02
Acarix AB Reports Earnings Results for the Full Year Ended December 31, 2023	15/02
Acarix AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	15/02
Acarix Seeks SEK33.7 Million from Share Issuance	02/02
Acarix Names New CEO	01/02
Acarix AB Announces CEO Changes	01/02
Acarix AB Advances the Utilization of Its CADScor System Within the Veterans Administration (Va) Healthcare Network	23/11
Transcript : Acarix AB, Q3 2023 Earnings Call, Nov 09, 2023	09/11
Acarix AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Transcript : Acarix AB - Special Call	13-10-23
Acarix CEO to Take Medical Leave; Acting CEO Appointed	03-10-23

Geen resultaten voor deze zoekopdracht